Evidence map›Paper›PMID 28724913›Full record

ArticleScientific reports2017

Time-averaged disease activity fits better joint destruction in rheumatoid arthritis.

Hideaki Tsuji, Koichiro Yano, Moritoshi Furu, Noriyuki Yamakawa, Katsunori Ikari, Motomu Hashimoto, Hiromu Ito, Takao Fujii, Wataru Yamamoto, Koichiro Ohmura and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Hideaki TsujiDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Koichiro YanoInstitute of Rheumatology, Tokyo Women's Medical University, 8-1, Kawada-cho, Sinjuku, 162-8666, Tokyo, Japan.
Moritoshi FuruDepartment of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Noriyuki YamakawaDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Katsunori IkariInstitute of Rheumatology, Tokyo Women's Medical University, 8-1, Kawada-cho, Sinjuku, 162-8666, Tokyo, Japan.
Motomu HashimotoDepartment of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Hiromu ItoDepartment of Orthopedic Surgery, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Takao FujiiDepartment of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Wataru YamamotoDepartment of Health Information Management, Kurashiki Sweet Hospital, Nakasho, 3542-1, Kurashiki, Japan.
Koichiro OhmuraDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Atsuo TaniguchiInstitute of Rheumatology, Tokyo Women's Medical University, 8-1, Kawada-cho, Sinjuku, 162-8666, Tokyo, Japan.
Shigeki MomoharaInstitute of Rheumatology, Tokyo Women's Medical University, 8-1, Kawada-cho, Sinjuku, 162-8666, Tokyo, Japan.
Fumihiko MatsudaDepartment of Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Cornelia F AllaartLeiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, The Netherlands.
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women's Medical University, 8-1, Kawada-cho, Sinjuku, 162-8666, Tokyo, Japan.
Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan.
Chikashi TeraoDepartment of Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, 606-8507, Kyoto, Japan. a0001101@kuhp.kyoto-u.ac.jp.
Kyoto University · JPTokyo Women's Medical University · JPKurashiki Central Hospital · JPKyoto Katsura Hospital · JPLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease activity of rheumatoid arthritis (RA), evaluated as Disease Activity Score (DAS), is associated with joint destruction. Since joint destruction reflects the history of disease activities, we hypothesized that time-averaged disease activity would better correlate with joint destruction than one-time disease activity. We recruited RA patients in IORRA (n = 557) and KURAMA (n = 204) cohorts, and calculated time-averaged DAS28 to model a modified Sharp/van der Heijde score (SHS). We evaluated the fitting of the model using time-averaged DAS28 among 1000 models in which we randomly picked up one-time DAS28. We also used clinical disease activity index (CDAI) or data in the BeSt study (European population). After conditioning on autoantibody and disease duration, time-averaged DAS28 showed significant improvement of model fitting compared with one-time DAS28 in both cohorts (p = 0.001 and 0.034, respectively). Time-averaged CDAI also showed a better fit. Integration of multiple DAS fit SHS better in the BeSt study. A good fit of time-averaged DAS could be observed using five to six time points of DAS. In conclusion, time-averaged disease activity fits the joint destruction model better than one-time disease activity. Usage of time-averaged disease activity as a covariate would increase the power of studies to identify novel correlates of joint destruction.

Indexed as

Arthritis, RheumatoidAsian PeopleCohort StudiesFemaleHumansJointsMaleMiddle AgedModels, BiologicalTime Factors

Identifiers

PMID28724913
PMCPMC5517434
OpenAlexW2735956878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.